3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Breast
1
Conditions
Colorectal Neoplasms
24
Neoplasms
12
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
5
Rectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Barrett Esophagus
4
Precancerous Conditions
3
Melanoma
3
Esophageal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Sarcoma
2
Primary Myelofibrosis
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Interventions
Blood Specimen Collection
9
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Surgical Procedures, Operative
3
Propofol
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Morphine
2
Laparoscopy
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Cyclophosphamide
2
Cetuximab
2
Carboplatin
2
Aspirin
2
Anesthesia, General
2
ribociclib
1
pertuzumab
1
osimertinib
1
jinfukang
1
eribulin
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplastic Cells, Circulating
×
Aspirin
×
Clear all
NCT05637567
2023-11-13
ASAP
German Cancer Research Center
Phase 2
Not yet recruiting
170 enrolled
NCT02602938
2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2
Unknown
40 enrolled